SCHEMBL6709159

SCHEMBL6709159

N#Cc1ccc(NC(=O)c2cc3cccc(NC(=O)c4cccc(F)c4)c3[nH]2)c(-c2noc(=O)[nH]2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.39
POLB P06746 1/20 0.39
MAPT P10636 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39
BRD4 O60885 1/20 0.37
HDAC1 Q13547 1/20 0.37
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
CYP1A2 P05177 3/20 0.36
CYP2C19 P33261 2/20 0.36
PLA2G7 Q13093 3/20 0.36
IRAK4 Q9NWZ3 1/20 0.35
PKM P14618 1/20 0.35
STK33 Q9BYT3 1/20 0.35
GRM5 P41594 1/20 0.35
KMT2A Q03164 3/20 0.35
MEN1 O00255 2/20 0.35
GPR35 Q9HC97 1/20 0.35
CYP3A4 P08684 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6710055 0.94 IRAK4 (0.41) RXFP1HDAC1NPC1RAB9ACYP1A2
SCHEMBL6708854 0.93 KMT2A (0.42) MAPTRXFP1HDAC1NPC1RAB9A
SCHEMBL6711406 0.90 GRIK1 (0.38) MAPTRXFP1HDAC1NPC1RAB9A
SCHEMBL6710411 0.89 PKM (0.45) TP53POLBMAPTRXFP1NPC1
SCHEMBL6711934 0.89 PRSS12 (0.39) MAPTRXFP1NPC1RAB9APLA2G7
SCHEMBL6710006 0.89 PARP14 (0.41) TP53POLBMAPTRXFP1BRD4
SCHEMBL6713656 0.88 GRIK1 (0.42) TP53POLBMAPTRXFP1NPC1
SCHEMBL6712044 0.88 GPR35 (0.46) TP53POLBMAPTRXFP1NPC1
SCHEMBL6711762 0.88 MAP3K5 (0.41) TP53POLBMAPTRXFP1NPC1
SCHEMBL6708809 0.87 IRAK4 (0.39) RXFP1HDAC1IRAK4GRM5GPR35

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 TP53 2699/4885POLB 626/4885MAPT 4754/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.